LIQUID E-Z-PAQUE Drug Patent Profile
✉ Email this page to a colleague
When do Liquid E-z-paque patents expire, and when can generic versions of Liquid E-z-paque launch?
Liquid E-z-paque is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in LIQUID E-Z-PAQUE is barium sulfate. One supplier is listed for this compound. Additional details are available on the barium sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIQUID E-Z-PAQUE?
- What are the global sales for LIQUID E-Z-PAQUE?
- What is Average Wholesale Price for LIQUID E-Z-PAQUE?
Summary for LIQUID E-Z-PAQUE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 1,537 |
| Patent Applications: | 2,088 |
| DailyMed Link: | LIQUID E-Z-PAQUE at DailyMed |
Recent Clinical Trials for LIQUID E-Z-PAQUE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ultragenyx Pharmaceutical Inc | Phase 2 |
| Jerry Vockley, MD, PhD | Phase 2 |
| University of California, San Francisco | Phase 4 |
Pharmacology for LIQUID E-Z-PAQUE
| Drug Class | Radiographic Contrast Agent |
| Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for LIQUID E-Z-PAQUE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | LIQUID E-Z-PAQUE | barium sulfate | SUSPENSION;ORAL | 208143-003 | Mar 1, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
